Neurovascular catheters market seen rising to $8.17 billion by 2030

The neurovascular catheters market is projected to grow from $4.87 billion in 2025 to $8.17 billion by 2030, driven by rising stroke treatment needs, an aging population and broader use of minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Neurovascular catheters are central to less invasive treatment of neurological blood vessel disorders, including embolic coil delivery and thrombectomy. - Market growth points to rising demand for stroke care, image-guided interventions and advanced catheter technology. - An aging population is increasing the number of patients at higher risk for cerebrovascular conditions.

What happened: - The neurovascular catheters market reached $4.87 billion in 2025 and is projected to rise to $5.38 billion in 2026. - The market is forecast to reach $8.17 billion by 2030. - The 2025-to-2026 increase reflects a 10.5% CAGR. - The 2026-to-2030 period is projected to grow at an 11.0% CAGR. - The Business Research Company released the market outlook on Aug. 19, 2026. - The report includes a free sample and the full market report.

The details: - Neurovascular catheters are inserted through the femoral or brachial arteries and guided to the brain. - The devices let physicians treat blood vessel disorders without direct incision into the skull or brain tissue. - Historical growth has been driven by more neurovascular disorders, wider use of minimally invasive neurosurgeries, broader access to interventional neuroradiology, improved catheter materials and more stroke treatment facilities. - Future growth is expected to come from higher thrombectomy demand, more investment in neurointerventional technology, greater use of imaging-assisted interventions and stronger preference for minimally invasive brain therapies. - Key market trends include steerable microcatheters, advanced embolization catheters, image-guided catheter navigation, and a greater focus on flexibility and precision. - The market report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Between the lines: - The forecast suggests neurointerventional care is moving further toward catheter-based procedures instead of open brain surgery. - The aging population backdrop gives the market a long runway, since older adults face higher rates of neurological disease. - The regional split points to a mature market in North America and a faster-expanding opportunity in Asia-Pacific as healthcare access improves. - In January 2024, the Population Reference Bureau said the number of Americans 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, a 47% increase. - The same projection puts that age group at 23% of the U.S. population, up from 17%.

What's next: - The market is likely to keep expanding as hospitals and specialists adopt more minimally invasive neurovascular techniques. - Demand should stay tied to stroke care capacity, imaging-based procedures and new catheter designs. - The report says upcoming 2026 editions will include market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, hotspot infographics and updated graphics and tables.

The bottom line: - Neurovascular catheters are becoming a larger global medtech market, with growth anchored by aging demographics, stroke treatment demand and continued shifts to minimally invasive care.